Brian Cooley is an accomplished pharmaceutical executive with a blend of technical and commercial leadership experiences across the biopharmaceutical value chain. Brian came to Sorrento Therapeutics with over 25 years of experience in commercial leadership and P&L roles both at Eli Lilly and at Genentech. In addition to leading large cross-functional teams, Brian has led multiple large business development deals and has worked in various partnering structures. Brian has deep therapeutic expertise across multiple disease areas including diabetes, immunology, and CNS; and speaks frequently at drug delivery conferences on human- centered design and commercial models in drug delivery. Brian received a BS in Chemical Engineering from Purdue University and a BA in Liberal Arts from DePauw University.
Dr. Russell Ross is the inventor of the Sofusa™ technology platform and co-founder of the Sofusa™ platform business unit within the Sorrento Therapeutics Corporation. Dr. Ross's expertise is in the area of Transport Phenomena for both biologic and chemical systems. For the past eight years, his primary activities have focused on the development of novel nanotopography biomaterials for therapeutic and cellular transport applications. Dr. Ross received his doctorate at the University of Wisconsin and he has been awarded more than 29 patents and has published 9 peer-reviewed papers.